Synthetic lethality: a step forward for personalized medicine in cancer

Area of Science:

• Oncology
• Genetics
• Pharmacology

Background:

• Synthetic lethality describes a genetic interaction where the simultaneous loss of function of two genes leads to cell death, while the loss of either gene alone is compatible with viability.
• Understanding the context-dependent nature of synthetic lethality is crucial for developing targeted cancer therapies.
• The rise of precision medicine in oncology necessitates the identification of reliable biomarkers to predict patient response to specific therapeutic interventions.

Purpose of the Study:

• To review recent advancements in synthetically lethal gene combinations within preclinical and clinical cancer research.
• To explore the potential of synthetic lethality as a strategy for discovering novel cancer drug combinations.
• To discuss the role of synthetically lethal gene interactions in identifying predictive biomarkers for precision cancer therapy.

Main Methods:

• Literature review of preclinical and clinical studies identifying synthetically lethal gene pairs in various cancer types.
• Analysis of the functional roles and therapeutic implications of reported synthetically lethal interactions.
• Discussion of the translation of preclinical findings into clinical applications and biomarker development.

Main Results:

• Several synthetically lethal gene combinations have been identified and are under investigation in preclinical and clinical settings.
• These interactions highlight potential vulnerabilities in cancer cells that can be exploited therapeutically.
• The identified gene pairs show promise as biomarkers for patient stratification and treatment selection.

Conclusions:

• Synthetic lethality represents a promising avenue for developing targeted cancer therapies and effective drug combinations.
• Elucidating synthetically lethal gene interactions is key to advancing precision medicine by providing robust biomarkers.
• Further research into synthetic lethality will facilitate the development of more personalized and effective cancer treatments.